Sarasin & Partners LLP lifted its position in Prologis, Inc. (NYSE:PLD – Free Report) by 0.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 936,862 shares of the real estate investment trust’s stock after purchasing an additional 2,814 shares during the quarter. Prologis accounts for approximately 1.1% of Sarasin & Partners LLP’s holdings, making the stock its 26th biggest holding. Sarasin & Partners LLP owned approximately 0.10% of Prologis worth $99,026,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in PLD. Semmax Financial Advisors Inc. acquired a new position in Prologis during the 2nd quarter worth about $27,000. Sunbelt Securities Inc. lifted its position in Prologis by 640.0% during the 2nd quarter. Sunbelt Securities Inc. now owns 259 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 224 shares in the last quarter. Dunhill Financial LLC lifted its position in Prologis by 239.5% during the 3rd quarter. Dunhill Financial LLC now owns 258 shares of the real estate investment trust’s stock worth $33,000 after buying an additional 182 shares in the last quarter. Hara Capital LLC acquired a new position in Prologis during the 3rd quarter worth about $48,000. Finally, Coastline Trust Co acquired a new position in Prologis during the 3rd quarter worth about $52,000. Institutional investors own 93.50% of the company’s stock.
Prologis Price Performance
NYSE PLD opened at $109.51 on Monday. The business has a 50 day simple moving average of $110.34 and a 200 day simple moving average of $118.33. Prologis, Inc. has a 52-week low of $100.82 and a 52-week high of $135.76. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.43 and a current ratio of 0.43. The stock has a market cap of $101.43 billion, a price-to-earnings ratio of 33.09, a PEG ratio of 2.85 and a beta of 1.09.
Prologis Dividend Announcement
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the stock. Scotiabank reduced their price target on shares of Prologis from $136.00 to $134.00 and set a “sector outperform” rating on the stock in a research report on Wednesday, December 4th. Barclays upped their target price on shares of Prologis from $131.00 to $132.00 and gave the company an “overweight” rating in a research report on Monday, November 18th. Truist Financial cut their target price on shares of Prologis from $132.00 to $121.00 and set a “buy” rating on the stock in a research report on Friday. BMO Capital Markets downgraded shares of Prologis from a “market perform” rating to an “underperform” rating and cut their target price for the company from $120.00 to $104.00 in a research report on Friday, December 6th. Finally, Mizuho cut their target price on shares of Prologis from $119.00 to $117.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $128.67.
Read Our Latest Analysis on Prologis
Prologis Company Profile
Prologis, Inc is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
Further Reading
- Five stocks we like better than Prologis
- What is Forex and How Does it Work?
- 3 Energy Storage Stocks Charging the Renewable Energy Sector
- Best Aerospace Stocks Investing
- Telecom Titans: Comparing Verizon and AT&T for Growth Potential
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Hims & Hers Health: A Stock to Trade or Own?
Receive News & Ratings for Prologis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prologis and related companies with MarketBeat.com's FREE daily email newsletter.